• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 780

Rebaudioside M

Intended Use: For use as a general-purpose sweetening agent in foods, excluding infant formula and products under USDAs jurisdiction, at levels in accordance with good manufacturing practices (GMP)
Basis: Scientific procedures
Notifier: Tate and Lyle
Notifier Address: 5450 Prairie Stone Parkway
Hoffman Estates, IL 60192
GRAS Notice (releasable information): GRN 780 (in PDF) (1 MB)
Date of closure: Jul 31, 2018
FDA's Letter: FDA has no questions (in PDF) (115 kB)